These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 807484

  • 1. Schistosoma mansoni: the role of the complement C3-activating system in the cercaricidal action of normal serum.
    Machado AJ, Gazzinelli G, Pellegrino J, Dias de Silva W.
    Exp Parasitol; 1975 Aug; 38(1):20-9. PubMed ID: 807484
    [No Abstract] [Full Text] [Related]

  • 2. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway.
    Fearon DT, Austen KF, Ruddy S.
    Rheumatology; 1975 Aug; 6():2-16. PubMed ID: 1105744
    [No Abstract] [Full Text] [Related]

  • 3. Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid.
    Des Prez RM, Bryan CS, Hawiger J, Colley DG.
    Infect Immun; 1975 Jun; 11(6):1235-43. PubMed ID: 806523
    [Abstract] [Full Text] [Related]

  • 4. [Complement activation and biological activities].
    Inoue K.
    Nihon Saikingaku Zasshi; 1976 Jul; 31(4):535-55. PubMed ID: 988219
    [No Abstract] [Full Text] [Related]

  • 5. Clearances of complement components, C3 proactivator and other serum proteins in chronic membranoproliferative glomerulonephritis (CMPGN).
    Geiger H, Good RA, Day NK.
    Clin Nephrol; 1975 Jul; 3(4):139-47. PubMed ID: 1149337
    [Abstract] [Full Text] [Related]

  • 6. Participation of an early component of complement and Hageman factor in C3 destruction by zymosan.
    Gigli I, Koethe S, Austen KF.
    Clin Immunol Immunopathol; 1975 Jul; 4(2):189-98. PubMed ID: 1170051
    [No Abstract] [Full Text] [Related]

  • 7. [Alternate complement pathway in Behçet disease (author's transl)].
    Kogure M, Ono Y.
    Nippon Ganka Gakkai Zasshi; 1975 Mar 10; 79(3):172-6. PubMed ID: 1171606
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Studies of the alternate pathway in chelated serum.
    Forsgren A, Mclean RH, Michael AF, Quie PG.
    J Lab Clin Med; 1975 Jun 10; 85(6):904-12. PubMed ID: 805816
    [Abstract] [Full Text] [Related]

  • 10. Activation of the alternative (properdin) pathway by divalent cations.
    Lew FT, Yukiyama Y, Waks HS, Osler AG.
    J Immunol; 1975 Sep 10; 115(3):884-8. PubMed ID: 807649
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction.
    Pinckard RN, Olson MS, Giclas PC, Terry R, Boyer JT, O'Rourke RA.
    J Clin Invest; 1975 Sep 10; 56(3):740-50. PubMed ID: 808560
    [Abstract] [Full Text] [Related]

  • 13. Evidence that C1s participates in the alternative complement pathway.
    Volanakis JE, Schultz DR, Stroud RM.
    Int Arch Allergy Appl Immunol; 1976 Sep 10; 50(1):68-80. PubMed ID: 1244208
    [Abstract] [Full Text] [Related]

  • 14. Activation of the complement system by antibody-antigen complexes: the classical pathway.
    Porter RR, Reid KB.
    Adv Protein Chem; 1979 Sep 10; 33():1-71. PubMed ID: 396780
    [No Abstract] [Full Text] [Related]

  • 15. EAC4 and EAC14 production without purified Ci.
    Linscott WD.
    J Immunol; 1975 Dec 10; 115(6):1625-30. PubMed ID: 241767
    [Abstract] [Full Text] [Related]

  • 16. Receptors for C3 on rat peritoneal mast cells.
    Sher A, McIntyre SL.
    J Immunol; 1977 Aug 10; 119(2):722-5. PubMed ID: 407303
    [Abstract] [Full Text] [Related]

  • 17. The proteolytic activation systems of complement.
    Reid KB, Porter RR.
    Annu Rev Biochem; 1981 Aug 10; 50():433-64. PubMed ID: 7023363
    [No Abstract] [Full Text] [Related]

  • 18. Structure and activation of the early components of complement.
    Porter RR.
    Fed Proc; 1977 Aug 10; 36(9):2191-6. PubMed ID: 328305
    [No Abstract] [Full Text] [Related]

  • 19. The effect of anticomplementary substances on properdin in normal and C2-deficient sera.
    McLean RH, Townsend K, Michael AF.
    Clin Exp Immunol; 1975 Mar 10; 19(3):435-44. PubMed ID: 1204244
    [Abstract] [Full Text] [Related]

  • 20. [Direct reaction between complement system and cell nuclei (author's transl)].
    Peltier AP, Cyna L, Solal LC, Dryll A.
    Ann Immunol (Paris); 1975 Mar 10; 126(2):177-89. PubMed ID: 172006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.